Alexandra Vallon Eberhart

With over 25 years of international experience in business development, innovation, and leadership, Dr Alexandra Vallon-Eberhard is committed to shaping the future of diagnostics. She currently serves as Senior Director – CTO, Global Strategy & Partnering at Roche Diagnostics, where she focuses on building strategic partnerships and ecosystems to advance patient-centric and solutionized diagnostics, as well as holistic lifecare management.

Previously, Alexandra co-led Signals Analytics from its inception through its acquisition by Kenshoo (now Skai), scaling the company to becoming the first worldwide end-to-end digital marketing platform. She has successfully advised more than 40 Fortune 500 companies on innovation and market strategies, and as a Partner at Cukierman Investment House, she supported the financial and operational growth of life science start-ups across Israel and Switzerland.

With a scientific background in immunology and virology, Alexandra earned her PhD at bioMérieux and completed postdoctoral research at the Weizmann Institute of Science, where she received six academic awards. She continues to contribute to the scientific community as Chairwoman of the Weizmann Young European Network, a member of the International Board of the Weizmann Institute, and an advisory board member to several organizations in digital health and longevity.

Driven by a strong belief in the power of curiosity and collaboration, Alexandra is passionate about creating meaningful innovations that improve human health.